Marc de Garidel | |
|---|---|
| Born | 1956 (age 67–68) Aix-en-Provence, France |
| Education | École Spéciale des Travaux Publics Thunderbird School of Global Management Harvard Business School |
| Occupation | Businessman |
| Known for | Former CEO, Ipsen (2010-16) |
| Title | CEO and Interim Board Chair Abivax |
| Term | 2016- |
| Honours |  Knight Legion of Honour (2008) |
Marc de Garidel is a French Biotech Entrepreneur. He is the CEO and Interim Board Chair of Abivax, a French clinical-stage, publicly traded biotechnology company (ABVX at Euronext Paris and Nasdaq Global Market), which he joined in May 2023.
He is also the non-executive chairman of the pharmaceutical company Ipsen since 2010. Further, he is on the board of Claris Bio, a Harvard Ophthalmology spin-off.